Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.
Mapp Biopharmaceutical, San Diego, California, USA.
J Virol. 2020 Mar 31;94(8). doi: 10.1128/JVI.02005-19.
Crimean-Congo hemorrhagic fever virus (CCHFV) is the causative agent of the most widespread tick-borne viral infection in humans. CCHFV encodes a secreted glycoprotein (GP38) of unknown function that is the target of a protective antibody. Here, we present the crystal structure of GP38 at a resolution of 2.5 Å, which revealed a novel fold primarily consisting of a 3-helix bundle and a β-sandwich. Sequence alignment and homology modeling showed distant homology between GP38 and the ectodomain of Gn (a structural glycoprotein in CCHFV), suggestive of a gene duplication event. Analysis of convalescent-phase sera showed high titers of GP38 antibodies indicating immunogenicity in humans during natural CCHFV infection. The only protective antibody for CCHFV in an adult mouse model reported to date, 13G8, bound GP38 with subnanomolar affinity and protected against heterologous CCHFV challenge in a STAT1-knockout mouse model. Our data strongly suggest that GP38 should be evaluated as a vaccine antigen and that its structure provides a foundation to investigate functions of this protein in the viral life cycle. Crimean-Congo hemorrhagic fever virus (CCHFV) is a priority pathogen that poses a high risk to public health. Due to the high morbidity and mortality rates associated with CCHFV infection, there is an urgent need to develop medical countermeasures for disease prevention and treatment. CCHFV GP38, a secreted glycoprotein of unknown function unique to the family, was recently shown to be the target of a protective antibody against CCHFV. Here, we present the crystal structure of GP38, which revealed a novel fold with distant homology to another CCHFV glycoprotein that is suggestive of a gene duplication event. We also demonstrate that antibody 13G8 protects STAT1-knockout mice against heterologous CCHFV challenge using a clinical isolate from regions where CCHFV is endemic. Collectively, these data advance our understanding of GP38 structure and antigenicity and should facilitate future studies investigating its function.
克里米亚-刚果出血热病毒(CCHFV)是人类中最广泛传播的蜱传病毒感染的病原体。CCHFV 编码一种未知功能的分泌糖蛋白(GP38),是保护性抗体的靶标。在这里,我们呈现了分辨率为 2.5Å 的 GP38 晶体结构,揭示了一种主要由 3 螺旋束和β三明治组成的新型折叠。序列比对和同源建模显示,GP38 与 Gn 的外域(CCHFV 中的一种结构糖蛋白)具有远缘同源性,提示发生了基因复制事件。对恢复期血清的分析表明,GP38 抗体的滴度很高,表明在自然 CCHFV 感染期间人类具有免疫原性。迄今为止,在成年小鼠模型中报告的唯一针对 CCHFV 的保护性抗体 13G8 以亚纳摩尔亲和力结合 GP38,并在 STAT1 敲除小鼠模型中保护免受异源 CCHFV 挑战。我们的数据强烈表明,GP38 应该作为疫苗抗原进行评估,并且其结构为研究该蛋白在病毒生命周期中的功能提供了基础。克里米亚-刚果出血热病毒(CCHFV)是一种对公共卫生构成高风险的优先病原体。由于与 CCHFV 感染相关的高发病率和死亡率,迫切需要开发用于疾病预防和治疗的医疗对策。CCHFV GP38 是一种分泌的糖蛋白,是 科特有的,其功能未知,最近被证明是针对 CCHFV 的保护性抗体的靶标。在这里,我们呈现了 GP38 的晶体结构,该结构揭示了一种与另一种 CCHFV 糖蛋白具有远缘同源性的新型折叠,提示发生了基因复制事件。我们还证明了抗体 13G8 使用来自 CCHFV 流行地区的临床分离株保护 STAT1 敲除小鼠免受异源 CCHFV 挑战。总的来说,这些数据提高了我们对 GP38 结构和抗原性的理解,并应有助于未来研究其功能。